By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Astellas Pharma US 

Agensys, Inc., a subsidiary of Astellas Pharma US
2225 Colorado Avenue
Santa Monica  California  90404  U.S.A.
Phone: 310-820-8029 Fax: 310-382-2802


SEARCH JOBS


Industry
Biotechnology






Company News
Agensys, Inc. And Sea Lane Biotechnologies, LLC Sign Commercial License Agreement For Antibodies Generated Using ConCIRT Libraries 6/2/2014 2:58:52 PM
Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of an Additional Antibody-Drug Conjugate (ADC) Under Existing Collaboration 6/27/2013 9:54:41 AM
Agensys, Inc. and Seattle Genetics, Inc. (SGEN) Announce Interim Phase I Data from ASG-5ME Clinical Trial for Prostate Cancer 6/4/2012 10:40:53 AM
Astellas Pharma Inc. (YPH.BE) Adds Two Key Senior Executives at Agensys, Inc. 12/1/2011 3:02:21 PM
Seattle Genetics, Inc. (SGEN) and Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), Announce Co-Development of Second Antibody-Drug Conjugate (ADC) Under Existing Collaboration 6/9/2011 9:27:27 AM
Agensys, Inc. Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President 11/2/2010 7:14:41 AM
Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE), and Seattle Genetics, Inc. (SGEN) Announce Initiation of Phase I Clinical Trial of ASG-5ME for Prostate Cancer 10/20/2010 10:27:54 AM
Seattle Genetics, Inc. (SGEN) Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE) 9/2/2010 10:44:59 AM
Seattle Genetics, Inc. (SGEN) Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, Inc., an Affiliate of Astellas Pharma Inc. (YPH.BE); Seattle Has Received $130 Million to date With Potential to Receive $2.7 Billion 9/2/2010 7:43:55 AM
Agensys, Inc. Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer 9/1/2010 8:18:50 AM
123
//-->